101 related articles for article (PubMed ID: 21718237)
1. Platelet and soluble glycoprotein VI - novel applications in diagnosis and therapy.
Bigalke B; Elvers M; Schönberger T; Gawaz M
Curr Drug Targets; 2011 Nov; 12(12):1821-30. PubMed ID: 21718237
[TBL] [Abstract][Full Text] [Related]
2. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome.
Bigalke B; Stellos K; Stakos D; Joos T; Pötz O; Geisler T; Bischofs C; Kremmer E; Krämer BF; Seizer P; May AE; Lindemann S; Gawaz M
Thromb Haemost; 2009 May; 101(5):911-5. PubMed ID: 19404545
[TBL] [Abstract][Full Text] [Related]
3. Implications of glycoprotein VI for theranostics.
Gawaz M; Vogel S; Pfannenberg C; Pichler B; Langer H; Bigalke B
Thromb Haemost; 2014 Jul; 112(1):26-31. PubMed ID: 24553806
[TBL] [Abstract][Full Text] [Related]
4. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
[TBL] [Abstract][Full Text] [Related]
5. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
6. Platelets in atherothrombosis--diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases.
Bigalke B; Schuster A; Sopova K; Wurster T; Stellos K
Curr Vasc Pharmacol; 2012 Sep; 10(5):589-96. PubMed ID: 22338574
[TBL] [Abstract][Full Text] [Related]
7. Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System.
Perrella G; Nagy M; Watson SP; Heemskerk JWM
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2681-2692. PubMed ID: 34496636
[TBL] [Abstract][Full Text] [Related]
8. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
[TBL] [Abstract][Full Text] [Related]
9. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic potentials of platelet glycoprotein VI.
Bigalke B; Krämer BF; Seizer P; Fateh-Moghadam S; Gawaz M; Lindemann S
Semin Thromb Hemost; 2010 Mar; 36(2):203-11. PubMed ID: 20414836
[TBL] [Abstract][Full Text] [Related]
11. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
[TBL] [Abstract][Full Text] [Related]
12. Platelet GPVI: a target for antithrombotic therapy?!
Dütting S; Bender M; Nieswandt B
Trends Pharmacol Sci; 2012 Nov; 33(11):583-90. PubMed ID: 22901552
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool.
Chatterjee M; Gawaz M
Platelets; 2017 Jun; 28(4):362-371. PubMed ID: 27753514
[TBL] [Abstract][Full Text] [Related]
14. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
15. [Advances of Studies on Platelet GPVI as Antithrombotic Target -Review].
Li P; Qiao JL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):264-269. PubMed ID: 28245414
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity.
Loyau S; Dumont B; Ollivier V; Boulaftali Y; Feldman L; Ajzenberg N; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):778-85. PubMed ID: 22155453
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction.
Seizer P; Borst O; Langer HF; Bültmann A; Münch G; Herouy Y; Stellos K; Krämer B; Bigalke B; Büchele B; Bachem MG; Vestweber D; Simmet T; Gawaz M; May AE
Thromb Haemost; 2009 Apr; 101(4):682-6. PubMed ID: 19350111
[TBL] [Abstract][Full Text] [Related]
18. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
[TBL] [Abstract][Full Text] [Related]
19. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
[TBL] [Abstract][Full Text] [Related]
20. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome.
Bigalke B; Lindemann S; Ehlers R; Seizer P; Daub K; Langer H; Schonberger T; Kremmer E; Siegel-Axel D; May AE; Gawaz M
Eur Heart J; 2006 Sep; 27(18):2165-9. PubMed ID: 16923742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
